Trials / No Longer Available
No Longer AvailableNCT00841451
Pulmonary Vein Isolation Outcomes With Fish Oils
Pulmonary Vein Isolation Outcomes With Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid (DHA)
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- St. Luke's-Roosevelt Hospital Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lovaza (Fish Oils) | Double blinded placebo controlled |
Timeline
- First posted
- 2009-02-11
- Last updated
- 2016-03-23
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00841451. Inclusion in this directory is not an endorsement.